alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
10.1


AGREEMENT
BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. DATED SEPTEMBER 28, 2015


WHEREAS
on June 23, 2015 Regen Biopharma, Inc. (“Regen”) entered into an agreement (“Agreement”) with Zander Therapeutics,
Inc. (“Zander”) whereby Regen granted to Zander an exclusive worldwide right and license for the development and commercialization
of certain intellectual property controlled by Regen (“License IP”) for non-human veterinary therapeutic use for a
term of fifteen years.


WHEREAS
pursuant to 3.1.1. Of the Agreement Zander shall pay to Regen one-time, non-refundable, upfront payment of one hundred thousand
US dollars ($100,000) as a license initiation fee (“Initiation Fee”)


WHEREAS
Zander desires to cause to be issued to Regen 8,000,000 common shares of Entest Biomedical Inc. on or before September 30, 2015
in full satisfaction of Zander’s obligations pursuant to 3.1.1 of the Agreement


WHEREAS
Regen is desirous of receiving 8,000,000 common shares of Entest Biomedical Inc. on or before September 30, 2015 in full satisfaction
of Zander’s obligations pursuant to 3.1.1 of the Agreement


THEREFORE,
IT IS AGREED AS FOLLOWS:


Zander
shall cause to be issued to Regen 8,000,000 common shares of Entest Biomedical Inc. on or before September 30, 2015 in full satisfaction
of Zander’s obligations pursuant to 3.1.1 of the Agreement


All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.


 


	REGEN
    BIOPHARMA INC.	ZANDER
    THERAPEUTICS INC.
	 	 
	By:
    /s/ David Koos	By: /s/
    David Koos
	 	 
	David
    R. Koos	David
    R. Koos 
	Chairman
    & CEO 	Chairman
    & CEO
<PAGE>

                                                                  EXHIBIT 12 (a)

<TABLE>
<CAPTION>
                     GENERAL ELECTRIC CAPITAL SERVICES, INC.
                           AND CONSOLIDATED AFFILIATES

                COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

                                                                        YEARS ENDED DECEMBER 31
                                                       --------------------------------------------------------
(Dollar amounts in millions)                              1996        1995        1994        1993        1992 
                                                       --------    --------    --------    --------    --------
<S>                                                    <C>         <C>         <C>         <C>         <C>     
Earnings from continuing operations ................   $  2,817    $  2,415    $  2,085    $  1,567    $  1,331
Provision for income taxes .........................      1,231       1,105         864         642         404
Minority interest ..................................        167         140         139         134          40
                                                       --------    --------    --------    --------    --------
Earnings before income taxes and minority interest .      4,215       3,660       3,088       2,343       1,775
                                                       --------    --------    --------    --------    --------
Fixed charges:
Interest ...........................................      7,402       6,731       4,598       3,585       3,780
One-third of rentals ...............................        182         175         156         138          92
                                                       --------    --------    --------    --------    --------
Total fixed charges ................................      7,584       6,906       4,754       3,723       3,872
                                                       --------    --------    --------    --------    --------
Less interest capitalized, net of amortization .....         41          21           9           4           6
                                                       --------    --------    --------    --------    --------
Earnings before income taxes and minority
  interest, plus fixed charges .....................   $ 11,758    $ 10,545    $  7,833    $  6,062    $  5,641
                                                       ========    ========    ========    ========    ========

Ratio of earnings to fixed charges .................       1.55        1.53        1.65        1.63        1.46
                                                       ========    ========    ========    ========    ========
</TABLE>
UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF OHIO

WESTERN DIVISION

SARA HAWES, et al., 

Plaintiffs,

v.

MACY’S, INC., et al.,

Defendants.

Case No. 1:17-cv-754

JUDGE DOUGLAS R. COLE

_____________________________________

CASSANDRA CHIARALUCE, et al., 

Plaintiffs,

v.

MACY’S, INC., et al.,

Defendants.

Case No. 2:20-cv-81

JUDGE DOUGLAS R. COLE

ORDER

Pursuant to the Joint Motion to Modify Class Notice and to Extend Deadlines, 

and for good cause shown, IT IS HEREBY ORDERED that the Notice Plan is modified 

to allow use of the proposed postcard notice attached as Exhibit 1 to the Declaration 

of Steve Platt. IT IS FURTHER ORDERED that the following deadlines are modified 

as set forward below:

Case: 1:17-cv-00754-DRC Doc #: 146 Filed: 06/21/23 Page: 1 of 2 PAGEID #: 4271
2

SO ORDERED.

June 21, 2023

DATE DOUGLAS R. COLE

UNITED STATES DISTRICT JUDGE

Description New dates

Notice to begin July 8, 2023

Plaintiffs’ motion 

concerning fees, expenses, 

and service awards due

August 6, 2023

Opt-out deadline September 6, 2023

Objection deadline September 6, 2023

Plaintiffs’ motion for final 

approval due

September 27, 2023

Deadline for Settlement 

Administrator to certify to 

Court concerning notice

October 6, 2023

Final approval hearing October 20, 2023

Case: 1:17-cv-00754-DRC Doc #: 146 Filed: 06/21/23 Page: 2 of 2 PAGEID #: 4272
Exhibit 10.7

 

MVC CAPITAL, INC.

AMENDMENT TO THE CUSTODY AGREEMENT

 

THIS AMENDMENT dated as of March 31, 2015, to the Custody Agreement, dated as of November 1, 2002, as amended February 10, 2006, May 1, 2006, June 14, 2006, April 6, 2009 and March 30, 2012 (the “Agreement”), is entered into by and between MVC Capital, Inc., a Delaware corporation (the “Corporation”) and U.S. Bank, N.A., a national banking association (the “Custodian”).

 

RECITALS

 

WHEREAS, the parties have entered into an Agreement; and

 

WHEREAS, the Corporation and the Custodian desire to amend the length of the Agreement; and

 

WHEREAS, Article XIV, Section 14.4 of the Agreement allows for an amendment by a written instrument executed by both parties.

 

NOW, THEREFORE, the parties agree as follows:

 

Section 10.1, effective period of the Agreement, is hereby superseded and replaced with the following Section 10.1:

 

10.1 Effective Period. This Agreement shall be effective as of March 31, 2015 and shall continue in full force and effect for three (3) years until terminated as hereinafter provided.

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by a duly authorized officer on one or more counterparts as of the date and year first written above.

 

	
MVC   CAPITAL, INC.
    	
 
    	
U.S.   BANK, N.A.
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
By:
    	
/s/ Scott   Schuenke
    	
 
    	
By:
    	
/s/ Michael R.   McVoy
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Printed Name:
    	
Scott Schuenke
    	
 
    	
Printed Name:   Michael R. McVoy
    
	
 
    	
 
    	
 
    
	
Title:
    	
CFO
    	
 
    	
Title: Senior   Vice President
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 538 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  2d Session
S. RES. 538

 Authorizing the use of the atrium in the Philip A. Hart Senate Office 
Building for the National Prescription Drug Take Back Day, a semiannual 
             event for the Drug Enforcement Administration.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 10, 2020

   Ms. Klobuchar (for herself and Mr. Blunt) submitted the following 
     resolution; which was referred to the Committee on Rules and 
                             Administration

_______________________________________________________________________

                               RESOLUTION

 
 Authorizing the use of the atrium in the Philip A. Hart Senate Office 
Building for the National Prescription Drug Take Back Day, a semiannual 
             event for the Drug Enforcement Administration.

    Resolved,

SECTION 1. USE OF THE ATRIUM IN THE HART SENATE OFFICE BUILDING FOR 
              TAKE BACK DAY.

    (a) Authorization.--The atrium in the Philip A. Hart Senate Office 
Building is authorized to be used on April 22, 2020, for the National 
Prescription Drug Take Back Day, a semiannual event of the Drug 
Enforcement Administration.
    (b) Preparations.--Physical preparations for the conduct of the 
event described in subsection (a) shall be carried out in accordance 
with such conditions as may be prescribed by the Sergeant at Arms and 
Doorkeeper of the Senate.
                                 <all>
```
Exhibit 32

                           CERTIFICATIONS PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Annual Report of Headwaters Incorporated
(the "Company") on Form 10-K for the year ended September 30, 2005 (the
"Report"), we, Kirk A. Benson, Chief Executive Officer of the Company, and Scott
K. Sorensen, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:

     (i)  The Report fully complies with the requirements of section 13(a) of
          the Securities Exchange Act of 1934; and

     (ii) The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


/s/ Kirk A. Benson
----------------------
Kirk A. Benson
Chief Executive Officer
Demember 2, 2005

/s/ Scott K. Sorensen
-----------------------
Scott K. Sorensen
Chief Financial Officer
December 2, 2005
# Fourth Court of Appeals **San Antonio, Texas**

J une 25, 2021
N o. 04-21-00028- CV
I N THE INTEREST OF N.M.B., A CHILD
F rom the 438th Judicial District C ourt, Bexar County, Texas Trial Court No. 2016- EM5 -06049 Honorable Antonia Arteaga, Judge Presiding


### ORDER
I n the underlying cause, Appellant Channel Beverly filed a petition in intervention in a suit affecting the parent

- child relationship. On January 20, 2021, the trial court signed an order dismissing her suit for lack of standing. On January 27, 2021, she filed a notice of appeal, stating her intent to appeal from this order by the trial cour t. On March 30, 2021, we issued an order explaining that the January 20, 2021 trial court order appeared to interlocutory because it did not dispose of all pending parties and claims in the underlying suit. Thus, we ordered Appellant Channel Beverly to sho w cause why this appeal should not be dismissed for lack of jurisdiction. We suspended appellate deadlines pending our determination of jurisdiction.
O n April 15, 2021, Appellant Channel Beverly responded to our show cause order by stating that “a heari ng to enter a final order” was set for April 21, 2021. On May 21, 2021, Appellant Shante Taylor filed a notice of appeal, stating her intent to appeal from the trial court’s final order signed on April 21, 2021. On May 24, 2021, a supplement clerk’s record was filed containing the trial court’s final order of April 21, 2021. We therefore conclude that we have jurisdiction over this appeal and reinstate appellate deadlines.
A t the time we suspended appellate deadlines, the reporter’s record was due. On Mar ch 29, 2021, Appellant Channel Beverly had filed a Statement of Inability to Afford Payment of Court Costs or an Appeal Bond. On June 22, 2021, the staff attorney to the Bexar County Civil District Courts filed a letter with this court informing us that th e trial court held a hearing on June 15, 2021 regarding Appellant Channel Beverly’s inability to afford costs, and determined that she had the ability to afford costs and would be allowed to pay under a payment plan. Given that arrangements are being made with the court reporter pursuant to the trial court , we ORDER the court reporter responsible for preparing the reporter’s record to file the reporter’s re cord on or before July 26, 2021

.

_________________________________ Li za A. Rodriguez, JusticeI N WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said court on this 25th day of June, 2021.

__________________________________ _ MICHAEL A. CRUZ , Clerk of Court
Exhibit
32.2





CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


(18
U.S.C. SECTION 1350)





In connection with the accompanying
Quarterly Report of Genta Incorporated (the “Company”) on Form 10-Q for the
quarter ended September 30, 2009 (the “Report”), I, Gary Siegel, Vice President,
Finance of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of Section 13(a) of the
      Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





Date:      November 16,
2009


/s/ GARY SIEGELName:
                Gary
      SiegelTitle:
                Vice
      President, Finance





* A
signed original of this written statement required by Section 906 has been
provided to Genta Incorporated and will be retained by Genta Incorporated and
furnished to the Securities and Exchange Commission or its staff upon
request.
**EXHIBIT
      32**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of AtheroGenics, Inc. (the “Company”) on
      Form 10-Q for the quarter ended March 31, 2006 as filed with the Securities
      and
      Exchange Commission on the date hereof (the “Report”), I, Russell M. Medford,
      President and Chief Executive Officer of the Company, certify, pursuant to
      18
      U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
      that, to the best of my knowledge:





(1)  The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





/s/RUSSELL
      M. MEDFORD


Russell
      M.
      Medford


President and Chief Executive Officer


Date: May 8, 2006














**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of AtheroGenics, Inc. (the “Company”) on
      Form 10-Q for the quarter ended March 31, 2006 as filed with the Securities
      and
      Exchange Commission on the date hereof (the “Report”), I, Mark P. Colonnese,
      Senior Vice President of Finance and Administration and Chief Financial Officer
      of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §
906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
      knowledge:





(1)  The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.






/s/MARK
      P. COLONNESE


Mark
      P.
      Colonnese


Senior
      Vice President
      of Finance and Administration


and
      Chief
      Financial Officer


Date:
      May 8,
      2006
1

IN THE UNITED STATES DISTRICT COURT

FOR THE SOUTHERN DISTRICT OF OHIO

WESTERN DIVISION AT DAYTON

CRAIG A. THOMPSON,

Petitioner, : Case No. 3:18-cv-117

- vs - District Judge Thomas M. Rose

Magistrate Judge Michael R. Merz

CHAE HARRIS, Warden,

 Warren Correctional Institution

:

Respondent.

ORDER DISSOLVING STAY AND SCHEDULING FURTHER 

FILINGS

This habeas corpus case is before the Court on Petitioner’s Status Report (ECF No. 63) 

indicating that the Second District Court of Appeals completed its review of this case on March 

31, 2020. While complete exhaustion of state court remedies would ordinarily require Petitioner 

to seek review by the Supreme Court of Ohio, Petitioner advises that because of the COVID-19

pandemic, that court has tolled Ohio court filing deadlines and it is unknown when that court’s 

processes may return to normal timing sequences. 

Given those circumstances, Petitioner asks the Court to excuse him from appealing to the 

Supreme Court of Ohio at this stage of the proceedings. The Magistrate Judge notes that the stahy 

in this case was entered sua sponte and in respect of comity for the Ohio courts. Respondent was 

willing to have the Court proceed to judgment on the State Court Record as it existed in November 

2018.

In the particular circumstances that present themselves in this Court at this stage of 

Case: 3:18-cv-00117-TMR-MRM Doc #: 64 Filed: 04/24/20 Page: 1 of 2 PAGEID #: 2606
2

proceedings, the Court finds that further appeal to the Supreme Court of Ohio would be futile and 

Petitioner is excused from pursuing that appeal in this instance.

Accordingly, the Stay of Proceedings is VACATED. Respondent shall supplement the 

State Court Record not later than June 1, 2020, as already filed with state court filings after the 

Stay was entered. Petitioner shall file his reply pleading not later than twenty-one days after the 

supplemental state court record is filed.

April 24, 2020.

s/ Michael R. Merz

 United States Magistrate Judge

Case: 3:18-cv-00117-TMR-MRM Doc #: 64 Filed: 04/24/20 Page: 2 of 2 PAGEID #: 2607
**EXHIBIT 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in theRegistration Statement (Form S-8, No. 333-65550) pertaining to the 1999 Stock Incentive Plan and Options Granted Pursuant to Agreements of Interep National Radio Sales, Inc., the Registration Statement (Form S-3, No. 333-89828) pertainingto the registration of 2,067,298 shares of Class A common stock, the Registration Statement (Form S-3, No. 333-97159) pertaining to the registration of 1,718,580 shares of Class A common stock and the Registration Statement (Form S-3,No. 333-101706) pertaining to the registration of 225,000 shares of Class A common stock of our report dated March 29, 2007, with respect to the consolidated financial statements and schedule of Interep National Radio Sales, Inc. includedin the Annual Report (Form 10-K) for the year ended December 31, 2006. 

/s/    BDO Seidman LLP

West Palm Beach, Florida 

April 2, 2007
SERVED MARCH 7, 2012 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF HEARFNGS • 

WASHINGTON, DC 

IN THE MATTER OF 

MONTGOMERY AVIATION, INC. 

FAA DOCKET NO. [TO BE ASSIGNED] 

(Civil Penalty Action) 

FDMS NO. FAA-2012-0023 

::--?ARTMEMlOf 

,.;L'iV_ 

7ili? HAR-8 A ^^38 

NOTICE OF ASSIGNMENT OF PROCEEDING 

This proceeding (heretofore designated as Case No. 2010-GL-l 1-0096) has been 

assigned to Administrative Law Judge J.E. Sullivan. All future pleadings and other 

communications regarding this proceeding shall be served on the Judge, the FAA Hearing 

Docket- and the other persons on the attached Service List. 

-Ronnie A. Yoder 

Chief Administrative LaWJudgeAttachment - Service List 
FDMS NO. FAA-2012-0023 

(Civil Penalty Action) 

SERVICE LIST 

ORIGINAL & ONE COPY 

Federal Aviation Administration 

800 Independence Avenue, S.W. 

Washington, DC 20591 

Attention: Hearing Docket Clerk, AGC-430 

Wilbur Wright Building—Suite 2WI000' 

ONE COPY 

J.C. Bnehler, Respondent's Counsel 

Buehler Associates 

777 East 86'^ Street 

Box 40924 

Indianapolis, IN 46240-0924 

TEL: 317-253-8686 

FAX: 317-253-9371 

Daniel Rex Montgomery, President 

Montgomery Aviation, Inc., Respondent 

Indianapolis Executive Airport 

11329 East State Road 32 

Zionsville. IN 46077 

Chris 0. Zurales, Complainant's Counsel 

Senior Attorney, Office of the Regional Counsel 

Great Lakes Region, AGL-7K 

Federal Aviation Administration 

2300 East Devon Avenue 

DesPlaines, IL 60018-4696 

TEL: 847-294-7713 

FAX: 847-294-7498 

The Honorable J.E. Sullivan, Administrative Law Judge 

U.S. Department of Transportation 

Office of Hearings, M-20 

1200 New Jersey Avenue, S.E. 

Washington, DC 20590 

TEL; 202-366-2132 

FAX: 202-366-7536 

Service was by U.S. Mail. For service in person or by expedited courier, use the following address: Federal 

Aviaiion Administraiion, 600 Independence Avenue, S.W., Wilbur Wright Building—Suite 2W1000, Washington, 

DC 2059 [; Attention: Hearing Docket Clerk, AGC-430. 

- 9 -
IN THE UNITED STATES DISTRICT COURT

FOR THE SOUTHERN DISTRICT OF OHIO

EASTERN DIVISION

United States of America

v. 2:18-cr-58 (6)

Judge Marbley

King Hamidu 

ORDER

There being no objections, the Court hereby adopts the Report

and Recommendation of the Magistrate Judge (ECF No. 129) that the

defendant’s guilty plea be accepted. The Court accepts the

defendant’s pleas of guilty to Count 1 Indictment, and he is hereby

adjudged guilty on this count. The Court will defer the decision

of whether to accept the plea agreement until the sentencing

hearing.

Date: May 2, 2019 s\Algenon L. Marbley 

 Algenon L. Marbley

 United States District Judge
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

ERIC MOCARSKI,

Appellant,

v.

GENESISCARE USA, INC., f/k/a 21st CENTURY ONCOLOGY, INC.,

Appellee.

No. 4D22-2601

[January 5, 2023]

Appeal of a non-final order from the Circuit Court for the Seventeenth 

Judicial Circuit, Broward County; Carlos A. Rodriguez, Judge; L.T. Case 

No. CACE22-003949.

William R. Amlong and Jennifer Daley of The Amlong Firm, Fort 

Lauderdale, for appellant.

Rodolfo Gomez of Fordharrison, LLP, Miami, and Tracey K. Jaensch of 

Fordharrison, LLP, Tampa, for appellee.

PER CURIAM.

Affirmed.

MAY, CONNER and KUNTZ, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.